Sun Pharma, ranbaxy’s new owner, has aggressive growth plans that don’t necessarily include brand Ranbaxy.

Meena Ganesh: The Caring Economy

Meena Ganesh has built home health-care startup Portea on the premise of complete accountability. The hitch: It has never been done before. (Ask Uber.)

The quirky chemist

Keki Gharda is the grand old man of the Indian chemical industry. but will his eccentricities as a businessman mar his legacy?

The new face of fitness tests

A biotech startup is using DNA testing to tell people what kind of activity they are most suited for.

Is Biocon undervalued?

The inability of analysts to fully understand biotech companies is keeping the value of Kiran Mazumdar-Shaw’s company down.

Reshaping the legacy

Is Dr. Reddy’s Laboratories missing its iconic founder?

An offbeat route to growth

Availability of sanitation facilities can help raise per capita income more than traditional methods.

New head. Newer thinking

Once set to be the largest domestic pharma player, Cipla lost out to more aggressive firms. Its new CEO is set to give the conservative company a fresh lease of life.

First stop India. Next Asia.

Fortis Healthcare is betting on the fast-growing Asia-Pacific economies to become a global hospital chain. It’s contrarian, it’s risky, but the Brothers Singh aren’t short on ideas.